Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-11-06

Clinical Trial Update: North American Prodromal Synucleinopathy Consortium Stage 2

View source ↗

Summary

This clinical trial update announces Stage 2 of the North American Prodromal Synucleinopathy Consortium, which is currently recruiting to study prodromal synucl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Washington University School of Medicine | Conditions: REM Sleep Behavior Disorder, Parkinson Disease | Status: RECRUITING